Free Trial
ASX:SMR

Stanmore Resources (SMR) Stock Price, News & Analysis

Stanmore Resources logo

About Stanmore Resources Stock (ASX:SMR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
3.20 million shs
Average Volume
N/A
Market Capitalization
A$1.48 billion
P/E Ratio
5.40
Dividend Yield
7.45%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SMR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stanmore Resources and its competitors with MarketBeat's FREE daily newsletter.

SMR Stock News Headlines

Ord Minnett Keeps Their Buy Rating on Stanmore Resources Ltd (SMR)
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
Citi Sticks to Their Buy Rating for Stanmore Resources Ltd (SMR)
See More Headlines

SMR Stock Analysis - Frequently Asked Questions

Stanmore Resources Limited (ASX:SMR) posted its quarterly earnings results on Tuesday, February, 12th. The company reported $0.08 earnings per share (EPS) for the quarter. Stanmore Resources had a net margin of 10.57% and a trailing twelve-month return on equity of 15.63%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Stanmore Resources investors own include Aldeyra Therapeutics (ALDX), Biodexa Pharmaceuticals (BDRX), Candel Therapeutics (CADL), Cleanspark (CLSK), CXApp (CXAI), DiaMedica Therapeutics (DMAC) and Dyne Therapeutics (DYN).

Company Calendar

Last Earnings
2/12/2019
Today
7/09/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Coking Coal
Sub-Industry
Fabricated Products
Current Symbol
ASX:SMR
CIK
N/A
Fax
N/A
Employees
440
Year Founded
N/A

Profitability

Trailing P/E Ratio
5.40
Forward P/E Ratio
N/A
P/E Growth
0.03
Net Income
A$268.40 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$2.54 billion
Price / Cash Flow
3.69
Book Value
A$1.95 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$1.48 billion
Optionable
Not Optionable
Beta
0.21
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (ASX:SMR) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners